https://www.selleckchem.com/pr....oducts/telotristat-e
05). At 7 days, moderate to strong immunolabeling was observed ( 0.05). After 30 days, the control and MTA-Fillapex groups exhibited strong immunolabeling, the white MTA-Angelus group exhibited moderate immunolabeling ( 0.05), and the Bio-C Sealer group exhibited low-to-moderate immunolabeling, differing significantly from the control ( 0.05). Bio-C Sealer and white MTA-Angelus exhibited greater cytocompatibility than MTA-Fillapex; all materials displayed adequate biocompatibility and induce
Like
Comment
Share
